Cargando…
Dexamethasone/piperacillin/tazobactam: Lack of efficacy following off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350302/ http://dx.doi.org/10.1007/s40278-021-00213-y |
Ejemplares similares
-
Amoxicillin/clavulanic-acid/dexamethasone/piperacillin/tazobactam: Lack of efficacy during off-label treatment of COVID-19 pneumonia: case report
Publicado: (2022) -
Piperacillin/tazobactam/tocilizumab: Trichosporon asahii infection and off-label-use: case report
Publicado: (2021) -
Dexamethasone: Lack of efficacy following off-label use: case report
Publicado: (2022) -
Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022) -
Dexamethasone: Lack of efficacy and off-label use: case report
Publicado: (2022)